SIG
AHCO icon

Stonegate Investment Group’s AdaptHealth AHCO Stock Holding History

Stonegate Investment Group’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26,244
Closed -$319K – 336
2023
Q2 		$319K Buy
+26,244
New +$292K 0.01% 244

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Stonegate Investment Group's AHCO Position: Q3 2023 in Review

Stonegate Investment Group sold out of AdaptHealth (AHCO) in Q3 2023, closing a stake of 26,244 shares — an estimated $319K sold.

Stonegate Investment Group first reported a position in AHCO in Q2 2023 and held it in 1 quarter. The position peaked at $319K in Q2 2023. 191 funds tracked by Wall St. Rank hold AHCO as of Q3 2023.

  • Stonegate Investment Group reported no remaining AdaptHealth position as of Q3 2023 after selling out during the quarter.
  • Stonegate Investment Group sold 26,244 AdaptHealth shares in Q3 2023, an estimated $319K.
  • Stonegate Investment Group first reported a position in AdaptHealth in Q2 2023 and held it in 1 quarter.
  • Stonegate Investment Group's AdaptHealth position peaked at $319K in Q2 2023.
  • 191 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2023.

Based on Stonegate Investment Group's 13F filing for Q3 2023, filed 24 Oct 2023.